A/APublished research associates this genotype with typical/baseline likelihood of Barrett's esophagus or Esophageal adenocarcinoma — no copies of the reported risk allele.
A/GPublished research associates this genotype (one copy of the reported risk allele) with an intermediate association with Barrett's esophagus or Esophageal adenocarcinoma.
G/GPublished research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Barrett's esophagus or Esophageal adenocarcinoma compared to the general population.
The Lancet. Oncology · 2016 · PMID 27527254 · open access
Questions about rs17451754
What is rs17451754?
rs17451754 is a single position in the genome, in or near the CFTR gene. Published research associates it with barrett's esophagus or esophageal adenocarcinoma. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.
Does rs17451754 affect how medicines work?
CFTR carries pharmacogenomic findings for Ivacaftor. That is educational information, not a prescription or a dosing guide. Any decision to start, stop or change a medicine belongs with the clinician or pharmacist managing your treatment.
Does having rs17451754 mean I will get this?
No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.
Where does the information about rs17451754 come from?
GWAS Catalog, Lancet Oncol 2016, PMID:27527254. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.